Reset Map4 Results
PO Box 11232, 21 Matt Drive, Fairfield, NJ 07004, U.S.AcceleDev Chemical headquartered in Cranbury, New Jersey, founded in 2003, is a custom synthesis company specializing in the design, development, and production of unique small molecules mainly for the pharmaceutical industry. Acceledev fully supports our partner’s Chemistry, manufacturing and control requirements and provides additional supplemental supply chain management services as well. About Acceledev Acceledev Chemical LLC, is a privately owned US based custom synthesis CDMO with small molecule synthetic chemistry research, process development and commercial scale production facilities located in the US and China. Acceledev offers a comprehensive range of small molecule process chemistry services in support of our Pharmaceutical partner’s API programs that are in the preclinical through commercialization phases. Acceledev’s services include process chemistry design, API process research and development, analytical method development, pilot scale-up, and commercial production within high quality multi-purpose facility sites. Acceledev fully supports our partner’s Chemistry, manufacturing and control requirements and provides additional supplemental supply chain management services as well. With a near 20 year highly track record of 1000’s successfully completed R&D projects, Acceledev has earned a strong industry reputation as an organization willing to accept and able to complete any type of highly challenging chemistry. All of this work has generated a compendium of in-house technology and helped fuel the company’s business growth and organizational expansions including a rise to 50 highly skilled/experienced organic process chemists and multiple large commercial China production sites. To learn more about Acceledev, please visit www.acceledev.com AcceleDev Chemical LLC, a global leader in custom synthesis services, proudly announces the opening of its state-of-the-art 5000 square foot R&D and GMP production facility located at 1 Duncan Drive, Cranbury, New Jersey. This significant expansion marks a new chapter in AcceleDev’s mission to provide cutting-edge chemistry solutions and support the development of new medicines. Founded in 2003 by Charlie Lewis, AcceleDev Chemical LLC has been at the forefront of custom synthesis, delivering innovative solutions to pharmaceutical companies worldwide. With this new facility, AcceleDev is set to enhance its capabilities in the R&D and production of early development active ingredients and intermediates, primarily serving the US pharmaceutical market. Charlie Lewis, Founder and Managing Director of AcceleDev Chemical LLC, expressed his excitement about the new facility: “This expansion is a testament to our commitment to innovation and excellence in chemistry. Our new lab in Cranbury not only increases our capacity but also strengthens our ability to support our partners in bringing new medicines to the market efficiently and safely.” Dr. Dave Tschaen, Chief Scientific Officer, who joined AcceleDev after a distinguished career at Merck Pharmaceutical, highlighted the advanced features of the new lab: “Our new facility will be equipped with GMP suites and cutting-edge technology, allowing us to perform high-level R&D and small-scale production under stringent quality standards. This move not only enhances our technical capabilities but also ensures that we continue to meet the expectations of our customers in delivering safe and effective pharmaceutical solutions.” AcceleDev’s decision to move to a larger laboratory space (5000 sq. ft.) in central New Jersey was driven by the need to expand its USA chemistry R&D and GMP small-scale production capabilities. This new space allows AcceleDev to become a higher-level active ingredient small-scale producer, more effectively supporting the introduction of new medicines to the marketplace. The facility’s GMP suites are expected to attract customers to visit, inspect, and approve the site, reinforcing confidence in AcceleDev’s commitment to quality and compliance. The new laboratory space in Central New Jersey features three process development rooms with 8 ft. hoods, an analytical lab, and two isolated GMP suites. This environment will enable AcceleDev to conduct high-quality research and production, ensuring compliance with the highest industry standards. AcceleDev Chemical LLC offers a comprehensive range of services. All custom synthesis projects are performed exclusively for customer partners, with rigorous protection of intellectual property and open sharing of new chemistry IP developed during projects. The company offers a broad spectrum of capabilities including full API process route design, development, and scale-up. With significant expertise in producing complex pharmaceutical targets, AcceleDev can perform synthetic routes of any length, from 1 to 20 steps or greater and any scale from mg to MT. The company’s organization includes 70 chemists, with 12 highly experienced PhDs. Primary Pharma FFS & FTE work is conducted at AcceleDev’s Shanghai and New Jersey R&D sites, while scale-up and commercial projects are executed at its Jiangyin and Dalian production sites in China. The US R&D team is small but rapidly growing, comprising 7 chemists, while the Shanghai team includes 40 chemists. About AcceleDev Chemical LLC AcceleDev Chemical LLC is a privately owned, US-based custom synthesis CDMO with small molecule synthetic chemistry research, process development, and commercial scale production facilities in the US and China. The company offers a comprehensive range of process chemistry services, including process design, API process research and development, analytical method development, pilot scale-up, and commercial production. AcceleDev supports its partners’ chemistry, manufacturing, and control requirements and provides supplemental supply chain management services. For more information, please contact: Charlie Lewis, Founder and Managing Director Email: Lewis@acceledev.com
Unit 2018-2020, Fortune Building, 359 Hongwu Road, Nanjing, 210002, ChinaAcceleDev Chemical headquartered in Cranbury, New Jersey, founded in 2003, is a custom synthesis company specializing in the design, development, and production of unique small molecules mainly for the pharmaceutical industry. Acceledev fully supports our partner’s Chemistry, manufacturing and control requirements and provides additional supplemental supply chain management services as well. About Acceledev Acceledev Chemical LLC, is a privately owned US based custom synthesis CDMO with small molecule synthetic chemistry research, process development and commercial scale production facilities located in the US and China. Acceledev offers a comprehensive range of small molecule process chemistry services in support of our Pharmaceutical partner’s API programs that are in the preclinical through commercialization phases. Acceledev’s services include process chemistry design, API process research and development, analytical method development, pilot scale-up, and commercial production within high quality multi-purpose facility sites. Acceledev fully supports our partner’s Chemistry, manufacturing and control requirements and provides additional supplemental supply chain management services as well. With a near 20 year highly track record of 1000’s successfully completed R&D projects, Acceledev has earned a strong industry reputation as an organization willing to accept and able to complete any type of highly challenging chemistry. All of this work has generated a compendium of in-house technology and helped fuel the company’s business growth and organizational expansions including a rise to 50 highly skilled/experienced organic process chemists and multiple large commercial China production sites. To learn more about Acceledev, please visit www.acceledev.com AcceleDev Chemical LLC, a global leader in custom synthesis services, proudly announces the opening of its state-of-the-art 5000 square foot R&D and GMP production facility located at 1 Duncan Drive, Cranbury, New Jersey. This significant expansion marks a new chapter in AcceleDev’s mission to provide cutting-edge chemistry solutions and support the development of new medicines. Founded in 2003 by Charlie Lewis, AcceleDev Chemical LLC has been at the forefront of custom synthesis, delivering innovative solutions to pharmaceutical companies worldwide. With this new facility, AcceleDev is set to enhance its capabilities in the R&D and production of early development active ingredients and intermediates, primarily serving the US pharmaceutical market. Charlie Lewis, Founder and Managing Director of AcceleDev Chemical LLC, expressed his excitement about the new facility: “This expansion is a testament to our commitment to innovation and excellence in chemistry. Our new lab in Cranbury not only increases our capacity but also strengthens our ability to support our partners in bringing new medicines to the market efficiently and safely.” Dr. Dave Tschaen, Chief Scientific Officer, who joined AcceleDev after a distinguished career at Merck Pharmaceutical, highlighted the advanced features of the new lab: “Our new facility will be equipped with GMP suites and cutting-edge technology, allowing us to perform high-level R&D and small-scale production under stringent quality standards. This move not only enhances our technical capabilities but also ensures that we continue to meet the expectations of our customers in delivering safe and effective pharmaceutical solutions.” AcceleDev’s decision to move to a larger laboratory space (5000 sq. ft.) in central New Jersey was driven by the need to expand its USA chemistry R&D and GMP small-scale production capabilities. This new space allows AcceleDev to become a higher-level active ingredient small-scale producer, more effectively supporting the introduction of new medicines to the marketplace. The facility’s GMP suites are expected to attract customers to visit, inspect, and approve the site, reinforcing confidence in AcceleDev’s commitment to quality and compliance. The new laboratory space in Central New Jersey features three process development rooms with 8 ft. hoods, an analytical lab, and two isolated GMP suites. This environment will enable AcceleDev to conduct high-quality research and production, ensuring compliance with the highest industry standards. AcceleDev Chemical LLC offers a comprehensive range of services. All custom synthesis projects are performed exclusively for customer partners, with rigorous protection of intellectual property and open sharing of new chemistry IP developed during projects. The company offers a broad spectrum of capabilities including full API process route design, development, and scale-up. With significant expertise in producing complex pharmaceutical targets, AcceleDev can perform synthetic routes of any length, from 1 to 20 steps or greater and any scale from mg to MT. The company’s organization includes 70 chemists, with 12 highly experienced PhDs. Primary Pharma FFS & FTE work is conducted at AcceleDev’s Shanghai and New Jersey R&D sites, while scale-up and commercial projects are executed at its Jiangyin and Dalian production sites in China. The US R&D team is small but rapidly growing, comprising 7 chemists, while the Shanghai team includes 40 chemists. About AcceleDev Chemical LLC AcceleDev Chemical LLC is a privately owned, US-based custom synthesis CDMO with small molecule synthetic chemistry research, process development, and commercial scale production facilities in the US and China. The company offers a comprehensive range of process chemistry services, including process design, API process research and development, analytical method development, pilot scale-up, and commercial production. AcceleDev supports its partners’ chemistry, manufacturing, and control requirements and provides supplemental supply chain management services. For more information, please contact: Charlie Lewis, Founder and Managing Director Email: Lewis@acceledev.com
11 Deerpark Dr, suite 119 Monmouth Jn, NJ, 08852 United StatesAcceleDev Chemical headquartered in Cranbury, New Jersey, founded in 2003, is a custom synthesis company specializing in the design, development, and production of unique small molecules mainly for the pharmaceutical industry. Acceledev fully supports our partner’s Chemistry, manufacturing and control requirements and provides additional supplemental supply chain management services as well. About Acceledev Acceledev Chemical LLC, is a privately owned US based custom synthesis CDMO with small molecule synthetic chemistry research, process development and commercial scale production facilities located in the US and China. Acceledev offers a comprehensive range of small molecule process chemistry services in support of our Pharmaceutical partner’s API programs that are in the preclinical through commercialization phases. Acceledev’s services include process chemistry design, API process research and development, analytical method development, pilot scale-up, and commercial production within high quality multi-purpose facility sites. Acceledev fully supports our partner’s Chemistry, manufacturing and control requirements and provides additional supplemental supply chain management services as well. With a near 20 year highly track record of 1000’s successfully completed R&D projects, Acceledev has earned a strong industry reputation as an organization willing to accept and able to complete any type of highly challenging chemistry. All of this work has generated a compendium of in-house technology and helped fuel the company’s business growth and organizational expansions including a rise to 50 highly skilled/experienced organic process chemists and multiple large commercial China production sites. To learn more about Acceledev, please visit www.acceledev.com AcceleDev Chemical LLC, a global leader in custom synthesis services, proudly announces the opening of its state-of-the-art 5000 square foot R&D and GMP production facility located at 1 Duncan Drive, Cranbury, New Jersey. This significant expansion marks a new chapter in AcceleDev’s mission to provide cutting-edge chemistry solutions and support the development of new medicines. Founded in 2003 by Charlie Lewis, AcceleDev Chemical LLC has been at the forefront of custom synthesis, delivering innovative solutions to pharmaceutical companies worldwide. With this new facility, AcceleDev is set to enhance its capabilities in the R&D and production of early development active ingredients and intermediates, primarily serving the US pharmaceutical market. Charlie Lewis, Founder and Managing Director of AcceleDev Chemical LLC, expressed his excitement about the new facility: “This expansion is a testament to our commitment to innovation and excellence in chemistry. Our new lab in Cranbury not only increases our capacity but also strengthens our ability to support our partners in bringing new medicines to the market efficiently and safely.” Dr. Dave Tschaen, Chief Scientific Officer, who joined AcceleDev after a distinguished career at Merck Pharmaceutical, highlighted the advanced features of the new lab: “Our new facility will be equipped with GMP suites and cutting-edge technology, allowing us to perform high-level R&D and small-scale production under stringent quality standards. This move not only enhances our technical capabilities but also ensures that we continue to meet the expectations of our customers in delivering safe and effective pharmaceutical solutions.” AcceleDev’s decision to move to a larger laboratory space (5000 sq. ft.) in central New Jersey was driven by the need to expand its USA chemistry R&D and GMP small-scale production capabilities. This new space allows AcceleDev to become a higher-level active ingredient small-scale producer, more effectively supporting the introduction of new medicines to the marketplace. The facility’s GMP suites are expected to attract customers to visit, inspect, and approve the site, reinforcing confidence in AcceleDev’s commitment to quality and compliance. The new laboratory space in Central New Jersey features three process development rooms with 8 ft. hoods, an analytical lab, and two isolated GMP suites. This environment will enable AcceleDev to conduct high-quality research and production, ensuring compliance with the highest industry standards. AcceleDev Chemical LLC offers a comprehensive range of services. All custom synthesis projects are performed exclusively for customer partners, with rigorous protection of intellectual property and open sharing of new chemistry IP developed during projects. The company offers a broad spectrum of capabilities including full API process route design, development, and scale-up. With significant expertise in producing complex pharmaceutical targets, AcceleDev can perform synthetic routes of any length, from 1 to 20 steps or greater and any scale from mg to MT. The company’s organization includes 70 chemists, with 12 highly experienced PhDs. Primary Pharma FFS & FTE work is conducted at AcceleDev’s Shanghai and New Jersey R&D sites, while scale-up and commercial projects are executed at its Jiangyin and Dalian production sites in China. The US R&D team is small but rapidly growing, comprising 7 chemists, while the Shanghai team includes 40 chemists. About AcceleDev Chemical LLC AcceleDev Chemical LLC is a privately owned, US-based custom synthesis CDMO with small molecule synthetic chemistry research, process development, and commercial scale production facilities in the US and China. The company offers a comprehensive range of process chemistry services, including process design, API process research and development, analytical method development, pilot scale-up, and commercial production. AcceleDev supports its partners’ chemistry, manufacturing, and control requirements and provides supplemental supply chain management services. For more information, please contact: Charlie Lewis, Founder and Managing Director Email: Lewis@acceledev.com
1 Duncan Dr Suite 2 Cranbury, NJ, 08512 United StatesAcceleDev Chemical headquartered in Cranbury, New Jersey, founded in 2003, is a custom synthesis company specializing in the design, development, and production of unique small molecules mainly for the pharmaceutical industry. Acceledev fully supports our partner’s Chemistry, manufacturing and control requirements and provides additional supplemental supply chain management services as well. About Acceledev Acceledev Chemical LLC, is a privately owned US based custom synthesis CDMO with small molecule synthetic chemistry research, process development and commercial scale production facilities located in the US and China. Acceledev offers a comprehensive range of small molecule process chemistry services in support of our Pharmaceutical partner’s API programs that are in the preclinical through commercialization phases. Acceledev’s services include process chemistry design, API process research and development, analytical method development, pilot scale-up, and commercial production within high quality multi-purpose facility sites. Acceledev fully supports our partner’s Chemistry, manufacturing and control requirements and provides additional supplemental supply chain management services as well. With a near 20 year highly track record of 1000’s successfully completed R&D projects, Acceledev has earned a strong industry reputation as an organization willing to accept and able to complete any type of highly challenging chemistry. All of this work has generated a compendium of in-house technology and helped fuel the company’s business growth and organizational expansions including a rise to 50 highly skilled/experienced organic process chemists and multiple large commercial China production sites. To learn more about Acceledev, please visit www.acceledev.com AcceleDev Chemical LLC, a global leader in custom synthesis services, proudly announces the opening of its state-of-the-art 5000 square foot R&D and GMP production facility located at 1 Duncan Drive, Cranbury, New Jersey. This significant expansion marks a new chapter in AcceleDev’s mission to provide cutting-edge chemistry solutions and support the development of new medicines. Founded in 2003 by Charlie Lewis, AcceleDev Chemical LLC has been at the forefront of custom synthesis, delivering innovative solutions to pharmaceutical companies worldwide. With this new facility, AcceleDev is set to enhance its capabilities in the R&D and production of early development active ingredients and intermediates, primarily serving the US pharmaceutical market. Charlie Lewis, Founder and Managing Director of AcceleDev Chemical LLC, expressed his excitement about the new facility: “This expansion is a testament to our commitment to innovation and excellence in chemistry. Our new lab in Cranbury not only increases our capacity but also strengthens our ability to support our partners in bringing new medicines to the market efficiently and safely.” Dr. Dave Tschaen, Chief Scientific Officer, who joined AcceleDev after a distinguished career at Merck Pharmaceutical, highlighted the advanced features of the new lab: “Our new facility will be equipped with GMP suites and cutting-edge technology, allowing us to perform high-level R&D and small-scale production under stringent quality standards. This move not only enhances our technical capabilities but also ensures that we continue to meet the expectations of our customers in delivering safe and effective pharmaceutical solutions.” AcceleDev’s decision to move to a larger laboratory space (5000 sq. ft.) in central New Jersey was driven by the need to expand its USA chemistry R&D and GMP small-scale production capabilities. This new space allows AcceleDev to become a higher-level active ingredient small-scale producer, more effectively supporting the introduction of new medicines to the marketplace. The facility’s GMP suites are expected to attract customers to visit, inspect, and approve the site, reinforcing confidence in AcceleDev’s commitment to quality and compliance. The new laboratory space in Central New Jersey features three process development rooms with 8 ft. hoods, an analytical lab, and two isolated GMP suites. This environment will enable AcceleDev to conduct high-quality research and production, ensuring compliance with the highest industry standards. AcceleDev Chemical LLC offers a comprehensive range of services. All custom synthesis projects are performed exclusively for customer partners, with rigorous protection of intellectual property and open sharing of new chemistry IP developed during projects. The company offers a broad spectrum of capabilities including full API process route design, development, and scale-up. With significant expertise in producing complex pharmaceutical targets, AcceleDev can perform synthetic routes of any length, from 1 to 20 steps or greater and any scale from mg to MT. The company’s organization includes 70 chemists, with 12 highly experienced PhDs. Primary Pharma FFS & FTE work is conducted at AcceleDev’s Shanghai and New Jersey R&D sites, while scale-up and commercial projects are executed at its Jiangyin and Dalian production sites in China. The US R&D team is small but rapidly growing, comprising 7 chemists, while the Shanghai team includes 40 chemists. About AcceleDev Chemical LLC AcceleDev Chemical LLC is a privately owned, US-based custom synthesis CDMO with small molecule synthetic chemistry research, process development, and commercial scale production facilities in the US and China. The company offers a comprehensive range of process chemistry services, including process design, API process research and development, analytical method development, pilot scale-up, and commercial production. AcceleDev supports its partners’ chemistry, manufacturing, and control requirements and provides supplemental supply chain management services. For more information, please contact: Charlie Lewis, Founder and Managing Director Email: Lewis@acceledev.com
Site Information
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
What is Scientist.com?
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
How can I use Scientist.com?
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Why should I place my order through Scientist.com?
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
How do I get my organization listed on the map?
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Information about my organization is incorrect, how do I fix it?
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.